Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.
Waterfowl represent the natural reservoir of all subtypes of influenza A viruses, including H5N1. Ducks are especially considered major contributors to the spread of H5N1 influenza A viruses because they exhibit diversity in morbidity and mortality. Therefore, as a preventive strategy against endemic as well as pandemic influenza, it is important to reduce the spread of H5N1 influenza A viruses in duck populations. Here, we describe the pathogenicity of dominant clades (clades 1 and 2) of H5N1 influenza A viruses circulating in birds in Asia. Four representatives of dominant clades of the viruses cause symptomatic infection but lead to different profiles of lethality in domestic ducks. We also demonstrate the efficacy, cross-protectiveness, and immunogenicity of three different inactivated oil emulsion whole-virus H5 influenza vaccines (derived by implementing reverse genetics) to the viruses in domestic ducks. A single dose of the vaccines containing 1 mug of hemagglutinin protein provides complete protection against a lethal A/Duck/Laos/25/06 (H5N1) influenza virus challenge, with no evidence of morbidity, mortality, or shedding of the challenge virus. Moreover, two of the three vaccines achieved complete cross-clade or cross-subclade protection against the heterologous avian influenza virus challenge. Interestingly, the vaccines induce low or undetectable titers of hemagglutination inhibition (HI), cross-HI, and/or virus neutralization antibodies. The mechanism of complete protection in the absence of detectable antibody responses remains an open question.
Kim
Jeong-Ki
JK
Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA.
Seiler
Patrick
P
Forrest
Heather L
HL
Khalenkov
Alexey M
AM
Franks
John
J
Kumar
Mahesh
M
Karesh
William B
WB
Gilbert
Martin
M
Sodnomdarjaa
R
R
Douangngeun
Bounlom
B
Govorkova
Elena A
EA
Webster
Robert G
RG
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000829:Animals, Domestic; D000914:Antibodies, Viral / Q000097:blood; D001208:Asia; D002988:Cloaca / Q000821:virology; D004372:Ducks; D006385:Hemagglutination Inhibition Tests; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology* / Q000472:pathogenicity*; D007252:Influenza Vaccines / Q000276:immunology*; D005585:Influenza in Birds / Q000517:prevention & control* / Q000821:virology*; D009821:Oils / Q000008:administration & dosage; D016019:Survival Analysis; D014132:Trachea / Q000821:virology; D015164:Vaccines, Inactivated / Q000276:immunology; D017201:Virus Shedding
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D007252:Influenza Vaccines; D009821:Oils; D015164:Vaccines, Inactivated
Lancet. 2004 Feb 21;363(9409):617-9
14987888
Avian Dis. 2001 Apr-Jun;45(2):355-65
11417815
Avian Dis. 2002 Jan-Mar;46(1):53-63
11924603
Virology. 1983 Sep;129(2):521-3
6623931
J Virol. 2007 Dec;81(23):12911-7
17881439
Microbiol Rev. 1992 Mar;56(1):152-79
1579108
Avian Dis. 1987 Jul-Sep;31(3):498-503
3118863
Virology. 2006 Aug 1;351(2):303-11
16690097
Avian Dis. 2003;47(3 Suppl):951-5
14575093
Virology. 1981 Sep;113(2):712-24
6267805
Virology. 2005 Oct 10;341(1):153-62
16084554
Bull World Health Organ. 1981;59(1):75-8
6973418
Virology. 2003 Sep 30;314(2):580-90
14554086
Vet Microbiol. 2000 May 22;74(1-2):15-27
10799775
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
10801978
Comp Immunol Microbiol Infect Dis. 1996 Jun;19(3):205-11
8800546
Dev Biol (Basel). 2006;124:61-7
16447495
Emerg Infect Dis. 2006 Jan;12(1):48-54
16494717
Vet Pathol. 1989 Jan;26(1):1-5
2643840
J Gen Virol. 2005 Feb;86(Pt 2):423-433
15659762
Emerg Infect Dis. 2006 Sep;12(9):1319-24
17073078
Lancet. 1998 Feb 14;351(9101):472-7
9482438
J Infect Dis. 2006 Jul 15;194(2):159-67
16779721
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10682-7
16030144
J Virol. 1986 May;58(2):655-6
3701925
Science. 2006 Apr 21;312(5772):384-8
16627734
Virology. 1999 Aug 15;261(1):15-9
10484749
Dev Biol (Basel). 2006;124:125-6
16450453
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10452-7
15235128
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12915-20
16118277
Emerg Infect Dis. 2004 Dec;10(12):2189-91
15663858
Comp Immunol Microbiol Infect Dis. 2009 Jul;32(4):351-63
18442853
Avian Pathol. 2004 Aug;33(4):405-12
15370037
Virology. 1982 Oct 15;122(1):38-47
6182687
Vaccine. 2002 Aug 19;20(25-26):3165-70
12163268
N Engl J Med. 2004 Mar 18;350(12):1179-88
14985470
Avian Dis. 1985 Jul-Sep;29(3):867-72
4074253
Virology. 1999 Feb 1;254(1):115-23
9927579
Virology. 2002 Jan 5;292(1):16-23
11878904
J Virol. 2004 May;78(9):4892-901
15078970
Avian Dis. 2007 Mar;51(1 Suppl):250-9
17494561
Nature. 2004 Jul 8;430(6996):209-13
15241415
Science. 1998 Jan 16;279(5349):393-6
9430591
Emerg Infect Dis. 2006 Feb;12(2):227-34
16494747
J Virol. 2005 Sep;79(17):11269-79
16103179
Nature. 1997 Oct 9;389(6651):554
9335492
Rev Sci Tech. 2000 Aug;19(2):463-82
10935274
J Immunol. 1998 Jan 1;160(1):322-7
9551987